Aerovate Therapeutics shares owned by UBS Group
Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Aerovate Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aerovate Therapeutics held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aerovate Therapeutics by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-03-31 | $22k | 8.8k | 2.51 |
| 2024-12-31 | $25k | 9.6k | 2.65 |
| 2024-09-30 | $13k | 6.3k | 2.09 |
| 2024-06-30 | $18k | 11k | 1.66 |
| 2024-03-31 | $332k | 11k | 29.57 |
| 2023-12-31 | $277k | 12k | 22.63 |
| 2023-09-30 | $152k | 11k | 13.57 |
| 2023-06-30 | $51k | 3.0k | 17.15 |
| 2023-03-31 | $121k | 6.0k | 20.17 |
| 2022-09-30 | $23k | 1.6k | 14.49 |
| 2021-12-31 | $6.0k | 484 | 12.40 |
| 2021-09-30 | $23k | 1.1k | 21.08 |
| 2021-06-30 | $47k | 2.1k | 22.93 |